We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Simple Contrast Ultrasound Scan Overcomes MR and CT Limitations in Diagnosing Tumors

By MedImaging International staff writers
Posted on 11 Sep 2023
Print article
Image: Simple contrast ultrasound scan resolves indeterminate MR and CT (Photo courtesy of Freepik)
Image: Simple contrast ultrasound scan resolves indeterminate MR and CT (Photo courtesy of Freepik)

Contrast-enhanced ultrasound (CEUS) takes traditional ultrasound imaging up a notch and is widely applied globally for diagnosing heart conditions and assessing the risk of heart attacks or strokes. CEUS also plays a role in identifying and assessing tumors in various organs like the liver, kidney, prostate, and breast, as well as in tracking the efficacy of cancer treatments. Unlike other imaging techniques, CEUS employs non-radioactive ultrasound contrast agents, also known as UCAs or UEAs, to enhance the quality and reliability of standard ultrasound images. The high-resolution, real-time images produced by CEUS often match the quality of those obtained from CT or MR scans. Moreover, ultrasound equipment is not only less costly than other diagnostic imaging tools like MRIs and CTs but is also portable, readily available, and can be taken directly to a patient's bedside if necessary.

CEUS can also be an invaluable resource for clarifying ambiguous MR and CT scan results, according to Dr. Stephanie Wilson, a clinical professor of radiology and gastroenterology at the University of Calgary (Alberta, Canada) and Co-President of the International Contrast Ultrasound Society (ICUS, Chicago, IL, USA). The ultrasound contrast agents used in CEUS consist of suspensions of tiny injectable "microbubbles" that pose no known risk of kidney damage, brain contrast deposit, or ionizing radiation exposure for patients and healthcare providers alike. These microbubbles remain within blood vessels and do not go into the tissue, thereby offering highly accurate blood flow details when compared to interstitial agents used in CT and MR imaging. This level of detail in blood flow is vital for diagnosing and characterizing tumors as well as for detecting recurrences post-treatment, she noted.

“CEUS often overcomes limitations of MR and CT in diagnosing many tumors and detecting their recurrence,” said Dr. Wilson. “CEUS scans are significantly less expensive than MR and CT.”

“In addition, in cystic neoplasms anywhere in the body, including the liver, small deposits of tumor are detected on high resolution CEUS with superior sensitivity when compared to MR, which doesn’t even show the nodule or blood flow,” Dr. Wilson added. “Further, for liver imaging, CEUS overcomes MR limitations associated with fat and iron.”

Related Links:
University of Calgary 
ICUS 

Gold Supplier
Ultrasound System
FUTUS LE
Gold Supplier
Conductive Gel
Tensive
Portable DR Flat Panel Detector
VIVIX-S 1012N
New
Mammography Diagnostic Station
Mammo Module

Print article
Radcal

Channels

Radiography

view channel
Image: Intelligent NR provides high-quality diagnostic images containing significantly less grainy noise (Photo courtesy of Canon)

AI-Driven DR System Produces Higher Quality Images While Limiting Radiation Doses in Pediatric Patients

Ionizing radiation is a fundamental element in producing diagnostic X-rays, yet it's widely acknowledged for its cancer risk potential. Digital projection radiography, a vital imaging modality, accounts... Read more

MRI

view channel
Image: The researchers are using MRI-guided radiation therapy that pairs daily MRIs with radiation treatment (Photo courtesy of Sylvester)

AI Technique Automatically Traces Tumors in Large MRI Datasets to Guide Real-time Glioblastoma Treatment

Treating glioblastoma, a prevalent and aggressive brain cancer, involves the use of radiation therapy guided by CT imaging. While this method is effective in targeting radiation, it doesn't provide real-time... Read more

Nuclear Medicine

view channel
Image: A novel PET radiotracer facilitates early, noninvasive detection of IBD (Photo courtesy of Karmanos)

New PET Radiotracer Aids Early, Noninvasive Detection of Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is an inflammatory condition of the gastrointestinal tract affecting roughly seven million individuals globally.... Read more

General/Advanced Imaging

view channel
Image: Artificial intelligence predicts therapy responses for ovarian cancer (Photo courtesy of 123RF)

AI Model Combines Blood Test and CT Scan Analysis to Predict Therapy Responses in Ovarian Cancer Patients

Ovarian cancer annually impacts thousands of women, with many diagnoses occurring at advanced stages due to subtle early symptoms. High-grade serous ovarian carcinoma, which accounts for 70-80% of ovarian... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Attendees can discover innovative products and technology in the RSNA 2023 Technical Exhibits (Photo courtesy of RSNA)

RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More

The 109th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA, Oak Brook, IL, USA) to be held in Chicago, Nov. 26 to 30 is all set to offer a vast array of medical... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.